Cysteamine as a novel disease-modifying compound for Parkinson's disease: Over a decade of research supporting a clinical trial
To date, medical and surgical interventions offered to patients with Parkinson's disease (PD) serve only to manage clinical symptoms; they have not shown the capacity to halt nor reverse degenerative processes. There is therefore an urgent need to identify and/or develop therapeutic strategies that...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2019-10-01
|
| Reeks: | Neurobiology of Disease |
| Online toegang: | http://www.sciencedirect.com/science/article/pii/S0969996119301986 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|